Literature DB >> 18419836

Distinct cognitive profiles and rates of decline on the Mattis Dementia Rating Scale in autopsy-confirmed frontotemporal dementia and Alzheimer's disease.

Katya Rascovsky1, David P Salmon, Lawrence A Hansen, Douglas Galasko.   

Abstract

Neuropsychological studies have shown that patients with Frontotemporal dementia (FTD) perform worse than patients with Alzheimer's disease (AD) on tests of conceptualization and verbal fluency, but better on tests of memory and visuospatial functions. However, it is not known if these distinct cognitive profiles are robust enough to be detected using a relatively brief dementia screening instrument such as the Mattis Dementia Rating Scale (MDRS). To address this issue, the MDRS subscale profiles of patients with autopsy-confirmed FTD (n = 17) or AD (n = 34) were compared. Results showed distinct cognitive profiles in which FTD patients performed worse than AD patients on the Initiation/Perseveration and Conceptualization subscales while performing better on the Memory and Construction subscales. The distinct subscale profiles correctly classified 85% of AD patients and 76% of FTD patients. Profiles were maintained in a subset of mildly-to-moderately demented patients (MDRS > or = 105) and correctly classified 89% of these patients. In addition, FTD patients (mean = 30.0 points/year) declined faster than AD patients (mean = 14.8 points/year) on MDRS total and specific subscale scores. These results suggest that the MDRS may be a useful adjunct to other clinical measures for distinguishing FTD from AD and tracking the progression of the disorder.

Entities:  

Mesh:

Year:  2008        PMID: 18419836      PMCID: PMC2864090          DOI: 10.1017/S135561770808051X

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  72 in total

1.  Predictors of mortality in frontotemporal dementia: a retrospective study of the prognostic influence of pre-diagnostic features.

Authors:  A Gräsbeck; E Englund; V Horstmann; U Passant; L Gustafson
Journal:  Int J Geriatr Psychiatry       Date:  2003-07       Impact factor: 3.485

2.  Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.

Authors:  J R Swartz; B L Miller; I M Lesser; A L Darby
Journal:  J Clin Psychiatry       Date:  1997-05       Impact factor: 4.384

3.  Rate of progression differs in frontotemporal dementia and Alzheimer disease.

Authors:  K Rascovsky; D P Salmon; A M Lipton; J B Leverenz; C DeCarli; W J Jagust; C M Clark; M F Mendez; D F Tang-Wai; N R Graff-Radford; D Galasko
Journal:  Neurology       Date:  2005-08-09       Impact factor: 9.910

4.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

5.  Measurement of functional activities in older adults in the community.

Authors:  R I Pfeffer; T T Kurosaki; C H Harrah; J M Chance; S Filos
Journal:  J Gerontol       Date:  1982-05

6.  Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease.

Authors:  R J Perry; J R Hodges
Journal:  Neurology       Date:  2000-06-27       Impact factor: 9.910

7.  Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia.

Authors:  A R Varma; J S Snowden; J J Lloyd; P R Talbot; D M Mann; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

8.  Behavioral quantitation is more sensitive than cognitive testing in frontotemporal dementia.

Authors:  Andrew Kertesz; Wilda Davidson; Patricia McCabe; David Munoz
Journal:  Alzheimer Dis Assoc Disord       Date:  2003 Oct-Dec       Impact factor: 2.703

9.  Altered serotonergic and cholinergic synaptic markers in Pick's disease.

Authors:  D L Sparks; W R Markesbery
Journal:  Arch Neurol       Date:  1991-08

10.  Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease.

Authors:  D J Connor; D P Salmon; T J Sandy; D Galasko; L A Hansen; L J Thal
Journal:  Arch Neurol       Date:  1998-07
View more
  24 in total

Review 1.  Visual spatial cognition in neurodegenerative disease.

Authors:  Katherine L Possin
Journal:  Neurocase       Date:  2010-06-02       Impact factor: 0.881

2.  Disease progression in C9orf72 mutation carriers.

Authors:  Mary K Floeter; Bryan J Traynor; Jennifer Farren; Laura E Braun; Michael Tierney; Edythe A Wiggs; Tianxia Wu
Journal:  Neurology       Date:  2017-06-14       Impact factor: 9.910

Review 3.  Distinguishing Alzheimer's disease from other major forms of dementia.

Authors:  Stella Karantzoulis; James E Galvin
Journal:  Expert Rev Neurother       Date:  2011-11       Impact factor: 4.618

4.  Both Financial and Cognitive Decline Predict Clinical Progression in MCI.

Authors:  Adam Gerstenecker; Kristen L Triebel; Roy Martin; Scott Snyder; Daniel C Marson
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jan-Mar       Impact factor: 2.703

Review 5.  Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes.

Authors:  Michał Harciarek; Stephanie Cosentino
Journal:  Int Rev Psychiatry       Date:  2013-04

Review 6.  Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration.

Authors:  Katya Rascovsky; Murray Grossman
Journal:  Int Rev Psychiatry       Date:  2013-04

7.  Differential longitudinal decline on the Mini-Mental State Examination in frontotemporal lobar degeneration and Alzheimer disease.

Authors:  Kay See Tan; David J Libon; Katya Rascovsky; Murray Grossman; Sharon X Xie
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Oct-Dec       Impact factor: 2.703

8.  Does cognitive self-consciousness link older adults' cognitive functioning to obsessive-compulsive symptoms?

Authors:  Caroline Prouvost; John E Calamari; John L Woodard
Journal:  Behav Res Ther       Date:  2016-07-31

9.  Cortical hyperexcitability in patients with C9ORF72 mutations: Relationship to phenotype.

Authors:  Olivia Schanz; Devin Bageac; Laura Braun; Bryan J Traynor; Tanya J Lehky; Mary Kay Floeter
Journal:  Muscle Nerve       Date:  2016-05-25       Impact factor: 3.217

10.  Impaired corticopontocerebellar tracts underlie pseudobulbar affect in motor neuron disorders.

Authors:  Mary Kay Floeter; Rohan Katipally; Meredith P Kim; Olivia Schanz; Matthew Stephen; Laura Danielian; Tianxia Wu; Edward D Huey; Avner Meoded
Journal:  Neurology       Date:  2014-07-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.